207 related articles for article (PubMed ID: 32981690)
21. Treatment of relapsed/refractory acute lymphoblastic leukemia.
Paul S; Rausch CR; Nasnas PE; Kantarjian H; Jabbour EJ
Clin Adv Hematol Oncol; 2019 Mar; 17(3):166-175. PubMed ID: 30969955
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Targeted Immunotherapy as Induction or Salvage Therapy in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
Ponvilawan B; Vittayawacharin P; Tunsing P; Owattanapanich W
Technol Cancer Res Treat; 2021; 20():15330338211037434. PubMed ID: 34350787
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
Mihăilă RG
Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
[TBL] [Abstract][Full Text] [Related]
24. Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia.
Proskorovsky I; Su Y; Fahrbach K; Vandendries E; Pagé V; Onyekwere U; Wang Y; Cappelleri JC; Stelljes M
Adv Ther; 2019 Aug; 36(8):2147-2160. PubMed ID: 31140123
[TBL] [Abstract][Full Text] [Related]
25. How should we treat older adults with Ph+ adult ALL and what novel approaches are being investigated?
Wieduwilt MJ
Best Pract Res Clin Haematol; 2017 Sep; 30(3):201-211. PubMed ID: 29050693
[TBL] [Abstract][Full Text] [Related]
26. Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age Spectrum.
Curran E; Muffly L; Luskin MR
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-11. PubMed ID: 35503981
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
Kansagra A; Litzow M
Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
[TBL] [Abstract][Full Text] [Related]
28. [Not Available].
Dourthe MÉ; Yakouben K; Chaillou D; Lesprit E; Dalle JH; Baruchel A
Bull Cancer; 2018 Dec; 105 Suppl 2():S147-S157. PubMed ID: 30686353
[TBL] [Abstract][Full Text] [Related]
29. Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia.
Brivio E; Bautista F; Zwaan CM
Haematologica; 2024 Jun; 109(6):1700-1712. PubMed ID: 38832425
[TBL] [Abstract][Full Text] [Related]
30. Novel antibody therapy in acute lymphoblastic leukemia.
Kochuparambil ST; Litzow MR
Curr Hematol Malig Rep; 2014 Jun; 9(2):165-73. PubMed ID: 24623281
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy in pediatric acute lymphoblastic leukemia.
Inaba H; Pui CH
Cancer Metastasis Rev; 2019 Dec; 38(4):595-610. PubMed ID: 31811553
[TBL] [Abstract][Full Text] [Related]
32. Adult Acute Lymphoblastic Leukemia.
Paul S; Kantarjian H; Jabbour EJ
Mayo Clin Proc; 2016 Nov; 91(11):1645-1666. PubMed ID: 27814839
[TBL] [Abstract][Full Text] [Related]
33. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.
O'Dwyer KM; Liesveld JL
Best Pract Res Clin Haematol; 2017 Sep; 30(3):184-192. PubMed ID: 29050691
[TBL] [Abstract][Full Text] [Related]
34. Recent Advances in Adult Acute Lymphoblastic Leukemia.
Richard-Carpentier G; Kantarjian H; Jabbour E
Curr Hematol Malig Rep; 2019 Apr; 14(2):106-118. PubMed ID: 30879177
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children.
Aldoss IT; Marcucci G; Pullarkat V
Oncology (Williston Park); 2016 Dec; 30(12):1080-91. PubMed ID: 27987201
[TBL] [Abstract][Full Text] [Related]
36. Antibody and cellular immunotherapies for acute lymphoblastic leukemia in adults.
Kimble EL; Cassaday RD
Leuk Lymphoma; 2021 Dec; 62(14):3333-3347. PubMed ID: 34402732
[TBL] [Abstract][Full Text] [Related]
37. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody-based therapies in the treatment of acute lymphoblastic leukemia.
Litzow MR
Am Soc Clin Oncol Educ Book; 2013; ():294-9. PubMed ID: 23714527
[TBL] [Abstract][Full Text] [Related]
39. Novel Therapies in Acute Lymphoblastic Leukemia.
Phelan KW; Advani AS
Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
[TBL] [Abstract][Full Text] [Related]
40. Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia.
Valecha GK; Ibrahim U; Ghanem S; Asti D; Atallah JP; Terjanian T
Expert Rev Hematol; 2017 Sep; 10(9):783-799. PubMed ID: 28666090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]